Erik R Swenson Selected Research

Acetazolamide (Diamox)

1/2022	Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
10/2021	Acetazolamide prevents hypoxia-induced reactive oxygen species generation and calcium release in pulmonary arterial smooth muscle.
1/2021	Acute Hemodynamic Effect of Acetazolamide in Patients With Pulmonary Hypertension Whilst Breathing Normoxic and Hypoxic Gas: A Randomized Cross-Over Trial.
12/2020	A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
10/2020	Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis.
4/2020	COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications.
1/2020	COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications.
1/2020	Influence of methazolamide on the human control of breathing: A comparison to acetazolamide.
1/2019	Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung.
1/2018	Effect of acetazolamide and methazolamide on diaphragm and dorsiflexor fatigue: a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik R Swenson Research Topics

Disease

29	Hypoxia (Hypoxemia) 10/2021 - 06/2002
23	Altitude Sickness (Mountain Sickness) 01/2022 - 02/2002
10	Acidosis 01/2021 - 08/2004
7	Pulmonary Edema 01/2022 - 10/2002
6	Ischemia 11/2021 - 01/2004
5	Reperfusion Injury 11/2021 - 09/2012
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 07/2017
4	Pulmonary Hypertension 01/2021 - 12/2004
4	COVID-19 01/2021 - 01/2020
4	Fatigue 01/2018 - 09/2013
3	Respiratory Acidosis 12/2021 - 05/2004
3	Alkalosis 12/2021 - 01/2016
3	Inflammation (Inflammations) 01/2021 - 03/2005
3	Neoplasms (Cancer) 01/2018 - 01/2016
3	Edema (Dropsy) 09/2012 - 05/2002
3	Pulmonary edema of mountaineers 03/2011 - 01/2009
3	Body Weight (Weight, Body) 01/2006 - 01/2002
2	Heart Failure 01/2022 - 04/2014
2	Infarction (Infarctions) 11/2021 - 01/2018
2	Dyspnea (Shortness of Breath) 01/2021 - 01/2020
2	Hypotension (Low Blood Pressure) 04/2020 - 01/2020
2	Hypocapnia 01/2020 - 08/2007
2	Hyperventilation 01/2020 - 08/2004
2	Hypercapnia 01/2020 - 08/2007
2	Proteinuria 01/2018 - 11/2011
2	Headache (Headaches) 01/2014 - 01/2007
2	Hemorrhage 04/2004 - 01/2004
1	Venous Thromboembolism 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2021
1	Infections 01/2021
1	Barotrauma 01/2021
1	Thrombosis (Thrombus) 10/2020
1	Glaucoma 10/2020
1	Critical Illness (Critically Ill) 01/2019
1	Dehydration (Water Stress) 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Cognitive Dysfunction 06/2017
1	Myocardial Infarction 11/2016

Drug/Important Bio-Agent (IBA)

30	Acetazolamide (Diamox)FDA LinkGeneric 01/2022 - 01/2004
15	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022 - 04/2006
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
7	Oxygen (Dioxygen)IBA 01/2021 - 03/2003
7	Carbon DioxideIBA 04/2020 - 05/2004
7	NitritesIBA 01/2019 - 02/2005
7	BenzolamideIBA 12/2018 - 07/2006
6	AcidsIBA 01/2022 - 04/2014
6	Carbonic Anhydrase InhibitorsIBA 10/2020 - 12/2015
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018 - 03/2005
4	Ethoxzolamide (Ethamide)FDA Link 11/2021 - 01/2007
4	Methazolamide FDA LinkGeneric 10/2020 - 04/2014
4	Hemoglobins (Hemoglobin)IBA 01/2018 - 02/2005
4	Bicarbonates (Hydrogen Carbonate)IBA 01/2018 - 04/2014
3	Protein Isoforms (Isoforms)IBA 11/2021 - 01/2016
3	CalciumIBA 11/2021 - 04/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2004
3	SodiumIBA 01/2020 - 01/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2008
2	ChloridesIBA 10/2020 - 01/2019
2	Vasodilator Agents (Vasodilators)IBA 04/2020 - 01/2020
2	SolutionsIBA 01/2020 - 08/2007
2	Sodium NitriteIBA 01/2019 - 09/2012
2	SulfonamidesIBA 01/2016 - 04/2007
2	Endothelins (Endothelin)IBA 10/2012 - 04/2004
2	Uric Acid (Urate)IBA 06/2010 - 06/2002
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	CalcineurinIBA 11/2021
1	triphosphoric acid (triphosphate)IBA 10/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2021
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2021
1	Inositol (Myoinositol)IBA 10/2021
1	SaltsIBA 01/2021
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2021
1	GasesIBA 01/2021
1	AlkaliesIBA 01/2021
1	DiureticsIBA 10/2020
1	matrigelIBA 01/2019
1	Crystalloid SolutionsIBA 01/2019
1	Saline SolutionIBA 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2018
1	CreatinineIBA 01/2018
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2018
1	Nitrite Reductases (Nitrite Reductase)IBA 01/2018
1	Protons (Proton)IBA 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 12/2017
1	Respiratory System Agents (Respiratory Stimulants)IBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016

Therapy/Procedure

3	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2006
2	Therapeutics 01/2021 - 05/2012
2	Drug Therapy (Chemotherapy) 01/2016 - 01/2016
1	Ambulatory Care (Outpatient Care) 01/2022
1	Wearable Electronic Devices 09/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Intravenous Administration 01/2021
1	Cannula 01/2021
1	Oral Administration 01/2020
1	Ligation 11/2016